Astec Lifesciences reports consolidated net loss of Rs 15.70 crore in the December 2025 quarter
Sales rise 32.88% to Rs 124.72 crore
Net Loss of Astec Lifesciences reported to Rs 15.70 crore in the quarter ended December 2025 as against net loss of Rs 40.38 crore during the previous quarter ended December 2024. Sales rose 32.88% to Rs 124.72 crore in the quarter ended December 2025 as against Rs 93.86 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales124.7293.86 33 OPM %3.19-6.12 -PBDT-2.37-13.75 83 PBT-13.59-25.15 46 NP-15.70-40.38 61Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content